These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 24570379)

  • 21. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
    Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
    Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
    van Amerongen MJ; van der Stok EP; Fütterer JJ; Jenniskens SF; Moelker A; Grünhagen DJ; Verhoef C; de Wilt JH
    Eur J Surg Oncol; 2016 Apr; 42(4):523-30. PubMed ID: 26856957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
    J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conversion therapy for synchronous colorectal liver metastases].
    Morohashi H; Yokoyama H; Akasaka H; Sakamoto Y; Koyama M; Murata A; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1665-7. PubMed ID: 24393882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
    Saxena A; Chua TC; Zhao J; Morris DL
    J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases.
    Beppu T; Hayashi N; Masuda T; Komori H; Horino K; Hayashi H; Okabe H; Baba Y; Kinoshita K; Akira C; Watanebe M; Takamori H; Baba H
    Anticancer Res; 2010 Mar; 30(3):1015-20. PubMed ID: 20393029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
    Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
    Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
    Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
    Popescu I; Alexandrescu S; Croitoru A; Boros M
    Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades.
    Viganò L; Russolillo N; Ferrero A; Langella S; Sperti E; Capussotti L
    Ann Surg Oncol; 2012 Jun; 19(6):2035-44. PubMed ID: 22219066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.